Unit

60 Degrees Pharmaceuticals Announces Closing of $2.4 Million Public Offering

Retrieved on: 
Wednesday, January 31, 2024

WASHINGTON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals , Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharmaceuticals” or the “Company”), specialists in developing and marketing new medicines for the treatment and prevention of infectious diseases, announced today the closing of its public offering of 5,260,901 units (the “Units”) at a price to the public of $0.385 per Unit and 999,076 pre-funded units (the “Pre-Funded Units”) at a price to the public of $0.375 per Pre-Funded Unit.

Key Points: 
  • WASHINGTON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals , Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharmaceuticals” or the “Company”), specialists in developing and marketing new medicines for the treatment and prevention of infectious diseases, announced today the closing of its public offering of 5,260,901 units (the “Units”) at a price to the public of $0.385 per Unit and 999,076 pre-funded units (the “Pre-Funded Units”) at a price to the public of $0.375 per Pre-Funded Unit.
  • Each Unit consists of one share of common stock and one warrant exercisable for one share of common stock (the “Warrant”).
  • The Pre-Funded Warrants are immediately exercisable and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full.
  • The gross proceeds to the Company from the offering were approximately $2.4 million, before deducting underwriter fees and other offering expenses payable by the Company.

60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million Public Offering

Retrieved on: 
Tuesday, January 30, 2024

WASHINGTON, Jan. 30, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals , Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharmaceuticals” or the “Company”), specialists in developing and marketing new medicines for the treatment and prevention of infectious diseases, announced today the pricing of its public offering of 5,260,901 units (the “Units”) at a price to the public of $0.385 per Unit and 999,076 pre-funded units (the “Pre-Funded Units”) at a price to the public of $0.375 per Pre-Funded Unit.

Key Points: 
  • WASHINGTON, Jan. 30, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals , Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharmaceuticals” or the “Company”), specialists in developing and marketing new medicines for the treatment and prevention of infectious diseases, announced today the pricing of its public offering of 5,260,901 units (the “Units”) at a price to the public of $0.385 per Unit and 999,076 pre-funded units (the “Pre-Funded Units”) at a price to the public of $0.375 per Pre-Funded Unit.
  • Each Unit consists of one share of common stock and one warrant exercisable for one share of common stock (the “Warrant”).
  • The closing of the offering is expected to occur on or about January 31, 2024, subject to the satisfaction of customary closing conditions.
  • The gross proceeds to the Company from the offering are expected to be approximately $2.4 million, before deducting underwriter fees and other offering expenses payable by the Company.

BIOVAXYS ANNOUNCES COMPLETION OF FIRST TRANCHE OF PRIVATE PLACEMENT

Retrieved on: 
Thursday, February 1, 2024

VANCOUVER, BC, Feb. 1, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it has completed the first tranche of a non-brokered private placement (the "Private Placement") consisting of 36,783,334 ("Units") at a price of $0.03 per Unit for total gross proceeds of $1,103,500.

Key Points: 
  • VANCOUVER, BC, Feb. 1, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it has completed the first tranche of a non-brokered private placement (the "Private Placement") consisting of 36,783,334 ("Units") at a price of $0.03 per Unit for total gross proceeds of $1,103,500.
  • Each Unit consists of one common share (a "Common Share") and one whole Common Share purchase warrant (a "Warrant").
  • The Company intends to use the net proceeds of the Private Placement for working capital purposes.
  • The Company anticipates closing the second and final tranche of the private placement no later than February 9th, 2024.

BIOVAXYS ANNOUNCES COMPLETION OF FIRST TRANCHE OF PRIVATE PLACEMENT

Retrieved on: 
Thursday, February 1, 2024

VANCOUVER, BC, Feb. 1, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it has completed the first tranche of a non-brokered private placement (the "Private Placement") consisting of 36,783,334 ("Units") at a price of $0.03 per Unit for total gross proceeds of $1,103,500.

Key Points: 
  • VANCOUVER, BC, Feb. 1, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces that it has completed the first tranche of a non-brokered private placement (the "Private Placement") consisting of 36,783,334 ("Units") at a price of $0.03 per Unit for total gross proceeds of $1,103,500.
  • Each Unit consists of one common share (a "Common Share") and one whole Common Share purchase warrant (a "Warrant").
  • The Company intends to use the net proceeds of the Private Placement for working capital purposes.
  • The Company anticipates closing the second and final tranche of the private placement no later than February 9th, 2024.

MineHub Upsizes Financing to $4 Million

Retrieved on: 
Monday, January 29, 2024

The closing of the Offering is subject to the Company's receipt of TSXV approval for the Offering.

Key Points: 
  • The closing of the Offering is subject to the Company's receipt of TSXV approval for the Offering.
  • The Company may pay finder's fees and grant finder's warrants under the Offering as permitted by TSXV policy and applicable securities laws.
  • All securities issued under the Offering will have a hold period of four months and a day from the date of issuance.
  • For further information regarding MineHub, please email [email protected] or visit our website at www.minehub.com .

Zacatecas Silver Arranges $1.8 Million Financing

Retrieved on: 
Monday, January 29, 2024

VANCOUVER, British Columbia, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Zacatecas Silver Corp. (“Zacatecas Silver” or the “Company”, ZAC:TSX Venture; ZCTSF: OTC Markets; 7TV: Frankfurt) is pleased to announce a non-brokered private placement financing of 18,000,000 units at a price of $0.10 per Unit for total proceeds of $1,800,000 (the “Offering”).

Key Points: 
  • VANCOUVER, British Columbia, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Zacatecas Silver Corp. (“Zacatecas Silver” or the “Company”, ZAC:TSX Venture; ZCTSF: OTC Markets; 7TV: Frankfurt) is pleased to announce a non-brokered private placement financing of 18,000,000 units at a price of $0.10 per Unit for total proceeds of $1,800,000 (the “Offering”).
  • Under the Offering, each Unit will consist of one common share (each, a “Common Share”); and one-half of one common share purchase warrant (each whole common share purchase warrant, a “Warrant”).
  • The securities under the Offering will be subject to restrictions on resale expiring four months and day after issue.
  • (Hons), PhD, FAusIMM (CP), FSEG, FGS, Chief Operating Officer of Zacatecas Silver.

CryoMass Announces Non-Dilutive Financing Agreement

Retrieved on: 
Monday, January 29, 2024

DENVER, Jan. 29, 2024 (GLOBE NEWSWIRE) -- CryoMass Technologies Inc. (the “Company” or “CryoMass”) (OTCQB: CRYM), a leader in cryogenic trichome-rich crops refinement systems, today announced that it has reached terms of an agreement with CRYM Co-Invest GP, a company affiliated with CryoMass (‘’GP”).

Key Points: 
  • DENVER, Jan. 29, 2024 (GLOBE NEWSWIRE) -- CryoMass Technologies Inc. (the “Company” or “CryoMass”) (OTCQB: CRYM), a leader in cryogenic trichome-rich crops refinement systems, today announced that it has reached terms of an agreement with CRYM Co-Invest GP, a company affiliated with CryoMass (‘’GP”).
  • Under the agreement, entities controlled by GP will have the right to purchase up to five CryoSift Separator™ Units (''Units”) from CryoMass for a total of up to US$6 million.
  • This innovative financing structure provides growth capital to CryoMass while enabling wider deployment of the Company's game-changing processing technology.
  • "This innovative financing agreement is key since it will allow us to more rapidly deploy our disruptive CryoSift Separators™ and drive adoption of our cutting-edge refinement process," said Christian Noël, CEO of CryoMass Technologies.

Purpose Investments Inc. Announces Termination of Purpose Energy Transition Fund

Retrieved on: 
Friday, January 26, 2024

TORONTO, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Purpose Investments Inc. (“Purpose”), in its capacity as manager and trustee of Purpose Energy Transition Fund (Ticker: CLMT) (the “Fund”), announced today that it would terminate the Fund effective on or about March 28, 2024 (the “Termination Date”).

Key Points: 
  • TORONTO, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Purpose Investments Inc. (“Purpose”), in its capacity as manager and trustee of Purpose Energy Transition Fund (Ticker: CLMT) (the “Fund”), announced today that it would terminate the Fund effective on or about March 28, 2024 (the “Termination Date”).
  • As a result, the termination, in the view of Purpose, is in the best interest of unitholders.
  • Purpose will redeem all of its issued and outstanding ETF units, Series A units, Series F units and Series I units of Purpose Energy Transition Fund (the “Units”).
  • It is anticipated that the ETF units of Purpose Energy Transition Fund will be voluntarily delisted from the Toronto Stock Exchange on or about March 25, 2024 (the “Delisting Date”), at the close.

Toronto Opens Its First Pickleball Club!

Retrieved on: 
Thursday, January 25, 2024

TORONTO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Toronto finally has its first exclusive indoor pickleball club!

Key Points: 
  • TORONTO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Toronto finally has its first exclusive indoor pickleball club!
  • The Jar Pickleball Club is having its Grand Opening from 12-5pm on Saturday, January 27th and Sunday, January 28th.
  • With pickleball’s meteoric rise in Toronto, the club couldn’t open soon enough.
  • The Jar Pickleball Club amenities include a lounge, sauna, cold plunge tub, locker room, and private showers and change rooms.

POET Technologies Announces Closing of C$6.2 Million Non-Brokered Private Placement of Units and Reports Preliminary Unaudited Fiscal Fourth Quarter and Fiscal Year 2024 Results

Retrieved on: 
Thursday, January 25, 2024

The Offering remains subject to final acceptance of the TSX Venture Exchange ("TSXV").

Key Points: 
  • The Offering remains subject to final acceptance of the TSX Venture Exchange ("TSXV").
  • Certain officers and directors of the Corporation have subscribed for an aggregate of 358,583 Units under the Offering for gross proceeds of approximately C$437,471 (US$322,725).
  • The Corporation is providing preliminary financial data in advance of its expected annual reporting on or before March 30, 2024.
  • Preliminary financial data on an unaudited basis as of December 31, 2023 are as follows (all amounts are approximate and stated in U.S. dollars):